Studies have shown that active fund managers routinely underperform the S&P500 index*​

Decoy Therapeutics Inc. (NASDAQ: DCOY)

DCOY Stock Predictions and Ratings

WSX Rating:
BUY
WSX Forecast (1yr):
8.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
88.20%

DCOY Stock Analysis

DCOY PE Ratio: 0.1

DCOY PEG Ratio: Not Available

DCOY Forward EPS Growth (12 month): 0.00%

DCOY PS Ratio:

DCOY PSG Ratio: Not Available

DCOY Forward Revenue Growth (12 month): 0.00%

DCOY Articles

No data was found